Mirador Capital Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,510
Closed -$519K 205
2024
Q1
$519K Sell
3,510
-14
-0.4% -$2.01K 0.1% 125
2023
Q4
$481K Sell
3,524
-984
-22% -$128K 0.1% 119
2023
Q3
$580K Buy
4,508
+629
+16% +$83.5K 0.13% 110
2023
Q2
$515K Sell
3,879
-199
-5% -$26.2K 0.12% 121
2023
Q1
$528K Buy
+4,078
New +$533K 0.13% 107
2018
Q1
Sell
-16,516
Closed -$1.37M 135
2017
Q4
$1.37M Buy
16,516
+435
+3% +$35.9K 0.75% 52
2017
Q3
$1.33M Buy
16,081
+174
+1% +$14K 0.78% 50
2017
Q2
$1.26M Buy
15,907
+524
+3% +$39.9K 0.77% 48
2017
Q1
$1.14M Buy
+15,383
New +$1.12M 0.83% 41
2016
Q4
Sell
-3,720
Closed -$268K 134
2016
Q3
$268K Sell
3,720
-340
-8% -$25K 0.24% 87
2016
Q2
$305K Buy
+4,060
New +$286K 0.31% 77

Other funds holding XLV

Mirador Capital Partners's XLV Position: Q2 2024 in Review

Mirador Capital Partners sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2024, closing a stake of 3,510 shares — an estimated $519K sold.

Mirador Capital Partners first reported a position in XLV in Q2 2016 and held it in 11 quarters. The position peaked at $1.37M in Q4 2017. 1,663 funds tracked by Wall St. Rank hold XLV as of Q2 2024.

  • Mirador Capital Partners reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2024 after selling out during the quarter.
  • Mirador Capital Partners sold 3,510 State Street Health Care Select Sector SPDR ETF shares in Q2 2024, an estimated $519K.
  • Mirador Capital Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2016 and held it in 11 quarters.
  • Mirador Capital Partners's State Street Health Care Select Sector SPDR ETF position peaked at $1.37M in Q4 2017.
  • 1,663 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2024.

Based on Mirador Capital Partners's 13F filing for Q2 2024, filed 12 Jul 2024.